Ophthalmic Solution Safety Profile: Active Surveillance of a Sodium Hyaluronate/Chondroitin Sulfate Combination in Peruvian Population.
Homero Contreras-SalinasMariana Barajas-HernándezLeopoldo Martín Baiza-DuránVanessa Orozco-CejaLourdes Yolotzin Rodríguez-HerreraPublished in: Drug, healthcare and patient safety (2021)
Good tolerability to the solution was identified, with a low incidence of ADRs. Just the same, all the associated ADRs were consistent with the information found in HUM's physicochemical profile and the physiopathology of DED. No unknown risks were identified, reinforcing HUM's safety profile.